Cigna Q2 adjusted revenue beats, lifts FY profit forecast on healthcare segment strength

Cigna group

30/07/2026 11:15

Overview
US health insurer's Q2 adjusted revenue beat analyst expectations, rising 7% yr/yr
Adjusted income from operations rose 6% yr/yr, driven by Cigna Healthcare growth
Company raised 2026 outlook for adjusted income from operations per share

Outlook
Cigna raises 2026 outlook for adj income from operations to at least $30.45 per share
Company expects Evernorth 2026 adj income from operations, pre-tax, at least $6,900 mln
Cigna Healthcare 2026 medical care ratio projected at 83.7% to 84.7%

Result Drivers
HEALTHCARE SEGMENT GROWTH - Cigna said Q2 adjusted income from operations rose due to higher contributions from Cigna Healthcare, including improved margin in U.S. Employer business
PREMIUM RATE INCREASES - Co said higher Cigna Healthcare revenue was primarily due to premium rate increases to cover expected medical cost increases
SPECIALTY VOLUME GROWTH - Co said Specialty and Care Services revenue and profit rose on strong specialty volume growth and higher generic and biosimilar adoption

Company press release: ID:nPn8DLCr3a

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
 
$71.67 bln
 
Q2 Adjusted Revenue
Beat
$71.56 bln
$70.34 bln (18 Analysts)
Q2 EPS
 
$6.29
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 21 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the managed healthcare peer group is "buy"
Wall Street's median 12-month price target for Cigna Group is $340.00, about 14.7% above its July 29 closing price of $296.47
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 9 three months ago

Reuters Recommended Reads
July 29 - Humana leaves annual adjusted profit outlook unchanged, shares drop
July 28 - Trump administration to end Medicare premium subsidy program
July 27 - Universal Health Services cuts 2026 forecast on Medicaid reimbursement uncertainty

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)